display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
breast cancer - adjuvant
breast cancer - adjuvant
cyclin inhibitor
abemaciclib based treatment
abemaciclib plus endocrine therapy MonarchE
palbociclib based treatment
palbociclib PALLAS
palbociclib plus endocrine therapy PENELOPE-B

Study type: